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Introduction:  Although shared decision making is recommended for cancer screening, it is not routinely completed 
in practice because of time constraints. We evaluated a process for improving decision making about 
colorectal cancer (CRC) screening using mailed decision aids (DAs) with follow-up telephone support 
in primary care practices.
Methods:  In three primary care practices, we identified patients aged 50–75 years who were not up to date with 
CRC screening. DAs were distributed via mail with telephone follow-up to eligible patients. Charts were 
reviewed six months later for CRC screening completion.
Results:  Among 1,064 eligible patients who received the mailed DA, 513 (48.2%) were reached by phone. 
During the six months after the intervention, 148/1064 (13.9%) patients were screened for CRC (4.8% 
underwent a fecal immunochemical test; 9.1% underwent colonoscopy). Younger patients (aged 50–54 
years) had higher rates of any screening (32.4%) compared with all other age groups (range 12.8–
19.6%). Medicaid patients had the lowest rates (4.0%) and insured patients had the highest rates 
(45.3%) of screening. Overall, 113/513 (22.0%) of patients who were reached by phone and 35/551 
(6.4%) of patients who were not reached by phone completed screening within six months.
Conclusion:  A standard process for identifying patients unscreened for CRC and DA distribution via mail with 
telephone decision support modestly increased CRC screening. This finding is consistent with the goal 
of providing preference-sensitive care and informed decision making. Improving care processes to 
include decision support outside of office visits is possible in primary care practices.
Keywords: informed decision making, screening, colorectal, underserved
Screening for colorectal cancer (CRC) is recommended by the U.S. Preventive Services Task Force and is known to 
reduce death from CRC.1 Lack of provider 
recommendation2,3 and patient awareness3 are both 
important contributors to insufficient screening. CRC 
screening recommendations for people at average 
risk starting at age 50 and continuing through age 
75 include either a stool-based test or a direct-
visualization test (colonoscopy or sigmoidoscopy). 
Offering a stool based test as an alternative to 
direct visualization for screening may be preferred 
by some patients, and it appears to increase patient 
participation in screening.4
Previous work highlighted the importance of 
improving the quality of medical decisions by 
eliciting and respecting patient preferences and 
values, and by encouraging practices, such as the 
use of decision aids (DAs).5 In the case of cancer 
screening, strong evidence from national surveys 
suggests that patients are not routinely involved in 
decision making.6 Providers may not have the time, 
skills, or resources they need to implement informed 
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decision making in clinical practice, particularly in 
the setting of a busy outpatient visit.7  
DAs can help communicate evidence-based 
information about the benefits and harms of 
health care choices, including cancer screening. 
In the case of CRC screening, DAs improve 
knowledge and interest in screening, and results 
in a higher likelihood of completing screening.8 
The many barriers that prevent routine use of DAs 
present daunting challenges, which have been 
demonstrated in prior studies.9–11 
The primary aim of this work was to develop a 
process to identify patients who were unscreened 
for CRC, distribute a CRC DA outside of the office 
setting with telephone decision support, promote 
informed decision making, and evaluate the 
feasibility and preliminary outcomes of that process 
in ambulatory settings.  
METHODS
Setting
The study setting consisted of primary care 
practices (two internal medicine and one family 
medicine) that were part of a single, large multi-
disciplinary practice with over 30% of patients 
either uninsured or receiving Medicaid. All three 
practices were training sites for internal medicine or 
family medicine residency programs, and all offered 
either fecal immunochemical test (FIT) or referred 
patients to gastroenterology for endoscopic CRC 
screening.  
Improvement Process
We used practice registry data to identify adults 
between the ages of 50 and 75 years old from 
the three practices in 2013 and 2014 (Figure 1). 
Using an algorithm-generated list of patient panels 
for the practices, we identified patients without 
documented CRC screening in electronic health 
record fields that corresponded to up-to-date 
screening by colonoscopy, flexible sigmoidoscopy, 
or stool testing. A member of the research team 
or a trained staff member from within the practice 
reviewed these medical records to further refine 
the cohort to patients who were due for CRC 
screening (i.e., they had not had a colonoscopy 
within 10 years, sigmoidoscopy within 5 years, or 
annual stool testing). We excluded patients who 
did not appear to speak English (the DA was only 
available in English), were inactive (no visit within 
the past 2 years), or were deceased. When the 
study started in 2013, the CRC screening rate for 
the three practices together was 52.7%, which was 
lower than the national rate at that time of 65.1%.12 
 
Following our screening for eligibility, primary care 
providers (PCPs) were given a list of their patients 
aged 50–75 years who appeared to be due for 
screening. PCPs were asked to exclude patients 
who had prior CRC or other indications for a different 
screening approach; were being actively treated for 
serious medical conditions, such as malignancy; 
or had advanced chronic disease with limited life 
expectancy, such as chronic obstructive pulmonary 
disease or chronic heart failure. PCPs were also 
asked to exclude patients with major mental illness, 
who might be more vulnerable to potential anxiety 
arising from receiving a mailed DA and might be 
better served with an in-office discussion. 
A letter signed by the PCP was mailed along with a 
booklet and DVD DA about CRC screening, created 
by the Informed Medical Decisions Foundation. The 
DA presented a balanced discussion of the risks 
and benefits of CRC screening, and a description 
of the available screening options. The information 
contained in the booklet was aimed at a sixth-grade 
reading level.  
Approximately two weeks after mailing of the DA, 
patients were called by a member of the primary 
care team at the practice site (either a registered 
nurse or medical assistant) for follow-up decision 
support. These team members underwent a one-
hour training that included an opportunity to view 
the DA and review the study design, a script for the 
telephone call, and instructions for provider follow 
up. Up to three calls were attempted for each patient 
over approximately two weeks. Decision support 
included querying patients about whether they 
watched the DVD and/or read the accompanying 
booklet, answering questions about screening 
options with pros and cons of each, and asking 
patients if they would like to set up a screening 
test. If the patient agreed, an electronic flag was 
sent to the provider to order the desired test (FIT 
or colonoscopy). Patients who requested an office 
visit to discuss screening further were scheduled for 
a visit if there was no upcoming visit. Chart reviews 
were completed six months after the DA mailing to 
determine if the patient had completed screening. 
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Figure 1: Implementation of Decision Aid Distribution at Primary Care Practice Sites
Outreach 
to practice 
directors
• Discuss concept of implementing practice-based decision aid distribution to 
appropriate patients.
• Discuss expectations of office and of support team. 
Meetings with 
office teams
• Review principles of decision aid use and view decision aid as a team to make all 
members aware of content.
• Discuss roles of team members in reviewing charts, answering questions, and 
making phone calls.
Review of 
registry data
• For each practice, generate list of patients aged 50-75 who appeared unscreened 
for colorectal cancer.
Chart review
• Identify team member at each site to complete chart review for the patients 
identified as unscreened.  Two sites used residents who had quality improvement 
project time, and one site used a new nurse practitioner who was awaiting 
licensing to see patients.
• At each site, extensive record review was completed to identify patients who had 
prior screening.  Because two of three practices had a prior electronic record, this 
included searching problem lists, consultant notes, health maintenance areas of 
the chart, and pathology results for polyp reports.
Primary care 
provider 
review
• Each primary care provider received a printed list of their patients who were 
unscreened.  They were asked to draw a line through names of patients who did 
not read English, were too medically ill (in their opinion) to undergo screening at 
that time, or who had major mental illness and might be frightened by receiving a 
decision aid via the mail.
Cover letter 
generation 
and mailing
• Office managers at each site used the refined patient lists to generate a cover 
letter for each patient signed by their primary care provider.
• Cover letters were inserted into packets with the DA (DVD and booklet) which 
were mailed to patients in batches every 2-3 weeks to stagger DA arrival.
Telephone 
follow up call 
and decision 
support
• A member of the primary care team called the patient approximately 2 weeks after 
the decision aid was mailed.  One practice used the Team RN to make the calls, 
the other practices used a medical assistant.  Up to three call attempts were made. 
If the patient stated they had not yet reviewed the materials but intended to do so, 
the team member asked if they could call back in 1 week to offer decision support. 
• If the patient had viewed the material or stated they did not intend to do so, the 
team member asked if the patient had any questions about CRC screening or about 
the materials.  After answering questions, the team member asked if the patient 
was interested in screening at that time, by either stool testing or colonoscopy.  A 
follow up visit to discuss the options with the primary provider was also offered. The 
discussion and decision were documented directly in the patient chart.  
• For patients who expressed a choice to begin screening, the team member sent an 
electronic flag to the provider requesting an order for the desired test (stool test or 
colonoscopy). 
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We used chi-square tests to compare proportions 
of patients receiving screening according to 
age, insurance type, gender, and completion of 
a decision support phone call. This study was 
reviewed and approved by the Institutional Review 
Board at Maine Medical Center.  
RESULTS
A cohort of 1064 patients who met inclusion criteria 
received the letter from their PCP along with the 
CRC-screening DA (Table 1). Of these patients, 
36.7% were 50–54 years old, 89.1% were white, 
51.4% were women, and 21.7% were uninsured. 
Overall 148/1064 (13.9%) patients were screened 
for CRC during the six months after the DA 
mailing (4.8% underwent FIT; 9.1% underwent 
colonoscopy).  
After the intervention, younger patients (50–54 
years) had the highest rates of any screening 
(32.4%) compared to all age groups (range 12.8%–
19.6%; p = 0.026). Medicaid patients had the 
lowest rates of screening completion (4.0%), while 
privately insured patients had the highest rates 
(45.3%; p = 0.003). We did not observe differences 
according to gender.
Practice members were able to reach 513 patients 
by phone for the decision support phone call 
within two weeks. They were not able to reach 551 
patients. Of those who were reached, 285 (55.6%) 
reported that they either watched the DVD or read 
the DA booklet, and 79 completed screening. 
While 228 (44.4%) patients reported they did not 
watch or read the materials, 34 of them completed 
screening. Overall, 113/513 (22.0%) patients who 
were reached by phone completed screening within 
six months, compared with 35/551 (6.4%) who were 
not reached by phone (p < 0.001).  
DISCUSSION
In this evaluation of a process for DA distribution 
with telephone follow up for CRC screening in 
primary care practices, we observed a modest 
impact of our intervention on CRC-screening rates. 
We noted marked differences in screening rates 
after the intervention according to insurance type. 
Medicaid patients had the lowest rate of screening, 
and privately insured patients had the highest rate. 
Patients more recently eligible for screening (aged 
50–54 years) were more likely to be screened than 
older patients.
Prior studies of mailed DAs in various settings are 
available for comparison of the effects on screening 
rates. Using a similar design of mailing letters from 
providers to unscreened patients and allowing the 
patient to request a DA, Lewis and colleagues 
reported a similar increase (15%) in CRC screening 
in the mailed DA group versus 4% in the control 
group.9 In other larger randomized studies, DAs 
resulted in more substantial increases in CRC 
screening among previously unscreened patients. 
For example, 39% of an intervention group were 
screened at 12 months versus 32% in a usual care 
group.13 In another randomized control trial of adults 
aged 70–84 years, 55% of the DA intervention 
group were screened at 6 months versus 45% in 
the control group.14 
Several characteristics of our practice population 
are notable and limit generalizability. At the 
inception of the study, the common practice of 
most providers was to recommend CRC screening 
starting at age 50 years with colonoscopy. Use 
of FIT testing was a more recent option for the 
practices, and providers may not have been offering 
this routinely as an option. The before-after design 
may have resulted in observations attributed to the 
intervention that were due to secular trends or other 
local effects. From discussions with practices, we 
estimate that the phone calls to patients took on 
average 15 minutes. However, we did not record 
these times and the time requirements likely varied. 
The relatively low proportion of patients who could 
be reached by phone is also a limitation, but the 
reasons for this are unclear. Patients who allow 
practices to contact them in general may be more 
likely to accept health advice and follow provider 
instructions. We had a high proportion of uninsured 
patients in this population. Both providers and 
patients may not have been aware of opportunities 
for screening subsidized by the hospital or other 
programs.
Because our implementation was relatively labor-
intensive, it is not clear whether other practices 
could reproduce this implementation model without 
adding responsibilities for staff members. However, 
use of electronic medical records that can be 
queried to ascertain cancer screening opportunities 
for patients in their population is becoming 
widespread. Using such queries could help improve 
processes to facilitate routine cancer screening and 
other population health management. 
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Characteristic Number Percent
Age Group (years)
     50-54 391 36.7%
     55-59 257 24.2%
     60-64 168 15.8%
     65-69 133 12.5%
     70-75 115 10.8%
Female sex 547 51.4%
Race
     White 948 89.1%
     Black 22 2.0%
     Other 20 1.9%
     Missing 74 7.0%
Insurance
     None 231 21.7%
     Medicaid 89 8.4%
     Medicare 310 29.1%
     Private 434 40.8%
Practice Site
     Practice 1 86 8.1%
     Practice 2 527 49.5%
     Practice 3 451 42.4%
     Table 1: Characteristics of the 1064 Patients in the Implementation Cohort
DVD is an outdated technology, and newer methods 
of delivering DA, such as through patient portals, is 
an alternative to mailing. 
Providing a DA to promote informed decision making 
and following up with patients in a timely way to 
support patient decisions and facilitate screening 
for those who desire it remains a challenge in 
clinical practice. Care models should incorporate 
best use of information systems and provide 
a rational process of care in a given system.7 
Outreach and education to patients beyond 
conventional office visits, but within the context 
of their trusted care team, may provide additional 
opportunities to promote informed choices about 
cancer screening. One growing opportunity is the 
use of patient portals for distributing DAs, and 
this approach should be studied. Bringing DAs 
into cancer screening processes will help improve 
knowledge about screening and incorporate 
patient preferences into screening choices. Future 
improvement efforts should also examine how 
often screening is routinely recommended and how 
options are provided. However, the health care 
team needs to be aware of patient preferences and 
open to providing options about screening modality, 
particularly in poor and low-literacy populations. 
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